Endotoxin Translocation and Gut Barrier Dysfunction Are Related to Variceal Bleeding in Patients With Liver Cirrhosis.

BACKGROUND

Bacterial infections are associated with the risk of variceal bleeding through complex pathophysiologic pathways.

OBJECTIVES

The primary objective of the present case-control study was to investigate the role of bacterial translocation and intestinal barrier dysfunction in the pathogenesis of variceal bleeding. A secondary objective was to determine independent predictors of key outcomes in variceal bleeding, including bleeding-related mortality.

METHODS

Eighty-four ( = 84) consecutive patients participated in the study, 41 patients with acute variceal bleeding and 43 patients with stable cirrhosis, and were followed up for 6 weeks. Peripheral blood samples were collected at patient admission and before any therapeutic intervention.

RESULTS

Child-Pugh (CP) score (OR: 1.868; = 0.044), IgM anti-endotoxin antibody levels (OR: 0.954; = 0.016) and TGF-β levels (OR: 0.377; = 0.026) were found to be significant predictors of variceal bleeding. Regression analysis revealed that albumin (OR: 0.0311; = 0.023), CRP (OR: 3.234; = 0.034) and FABP2 levels (OR:1.000, = 0.040), CP score (OR: 2.504; = 0.016), CP creatinine score (OR: 2.366; = 0.008), end-stage liver disease model (MELD), Na (OR: 1.283; = 0.033), portal vein thrombosis (OR: 0.075; = 0.008), hepatocellular carcinoma (OR: 0.060; = 0.003) and encephalopathy (OR: 0.179; = 0.045) were significantly associated with 6-week mortality.

CONCLUSIONS

Bacterial translocation and gut barrier impairment are directly related to the risk of variceal bleeding. Microbiota-modulating interventions and anti-endotoxin agents may be promising strategies to prevent variceal bleeding.